Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue factor pathway inhibitor alpha (TFPIα) is a key endogenous anticoagulant protein that regulates the initiation of blood coagulation. It acts primarily by inhibiting the tissue factor (TF)-induced coagulation pathway, specifically targeting and neutralizing the catalytic activity of factor Xa (FXa) and providing feedback inhibition to the TF-factor VIIa complex in the presence of FXa. It is the predominant isoform in humans and is found both as a soluble protein in plasma and associated with cell surfaces, particularly on endothelial cells.
Direct inhibition of Factor Xa and feedback inhibition of FVIIa/TF complex
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue Factor Pathway Inhibitor Alpha (None).